Darunavir
NDC 59651-085, Darunavir, tablet, film coated, from Aurobindo Pharma Limited.
- Product NDC
- 59651-085
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210677
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59651-085 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DARUNAVIR PROPYLENE GLYCOLATE600 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; HIV Protease Inhibitors [MoA]; Protease Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59651-085-60 | 59651008560 | 60 TABLET, FILM COATED in 1 BOTTLE (59651-085-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/88910ad0-6dc3-4a47-8a6b-5c6ee79f2a93NADAC price for package 59651008560
GET /v1/drugs/nadac/59651008560
Use it
Look up 59651-085 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59651-085 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59651-085. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.